Your browser doesn't support javascript.
loading
Somatic targeted mutation profiling of colorectal cancer precursor lesions.
Dos Santos, Wellington; Dos Reis, Mariana Bisarro; Porto, Jun; de Carvalho, Ana Carolina; Matsushita, Marcus; Oliveira, Gabriela; Syrjänen, Kari; Reis, Rui Manuel; Guimarães, Denise Peixoto.
Affiliation
  • Dos Santos W; Molecular Oncology Research Center, Barretos Cancer Hospital, Rua Antenor Duarte Vilela, 1331, Barretos, SP, 14784-400, Brazil.
  • Dos Reis MB; Molecular Oncology Research Center, Barretos Cancer Hospital, Rua Antenor Duarte Vilela, 1331, Barretos, SP, 14784-400, Brazil.
  • Porto J; Molecular Oncology Research Center, Barretos Cancer Hospital, Rua Antenor Duarte Vilela, 1331, Barretos, SP, 14784-400, Brazil.
  • de Carvalho AC; Molecular Oncology Research Center, Barretos Cancer Hospital, Rua Antenor Duarte Vilela, 1331, Barretos, SP, 14784-400, Brazil.
  • Matsushita M; Department of Pathology, Barretos Cancer Hospital, Barretos, Brazil.
  • Oliveira G; Research and Education Institute, Barretos Cancer Hospital, Barretos, Brazil.
  • Syrjänen K; Molecular Oncology Research Center, Barretos Cancer Hospital, Rua Antenor Duarte Vilela, 1331, Barretos, SP, 14784-400, Brazil.
  • Reis RM; SMW Consultants Ltd, Kaarina, Finland.
  • Guimarães DP; Department of Clinical Research, Biohit Oyj, Helsinki, Finland.
BMC Med Genomics ; 15(1): 143, 2022 06 28.
Article in En | MEDLINE | ID: mdl-35761395
BACKGROUND: Most colorectal cancers (CRC) arise from precursor lesions. This study aimed to characterize the mutation profile of colorectal cancer precursor lesions in a Brazilian population. METHODS: In total, 90 formalin-fixed paraffin-embedded colorectal precursor lesions, including 67 adenomas, 7 sessile serrated lesions, and 16 hyperplastic polyps, were analyzed by next-generation sequencing using a panel of 50 oncogenes and tumor suppressor genes. The genetic ancestry of the patients was estimated. RESULTS: Somatic driver mutations were identified in 66.7% of cases, including alterations in APC (32.2%), TP53 (20.0%), KRAS (18.9%), BRAF (13.3%) and EGFR (7.8%). Adenomas displayed a higher number of mutations, mainly in APC, compared to serrated polyps (73.1% vs. 47.8%, p = 0.026). Advanced adenomas had a significantly higher frequency of mutation in KRAS and a high overall mutation rate than early adenomas (92.9% vs. 59%, p = 0.006). A high degree of ancestry admixture was observed in the population studied, with a predominance of European components (mean of 73%) followed by African (mean of 11.3%). No association between genetic ancestry and type of lesions was found. The mutation profile of Brazilian colorectal precursor lesions exhibits alteration in APC, KRAS, TP53, and BRAF at different frequencies according to lesion type. CONCLUSIONS: These results bestow the knowledge of CRC's biologic history and support the potential of these biomarkers for precursor lesions detection in CRC screening of the Brazilian population.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Adenoma / Colonic Polyps Type of study: Prognostic_studies Limits: Humans Language: En Journal: BMC Med Genomics Journal subject: GENETICA MEDICA Year: 2022 Document type: Article Affiliation country: Brazil Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Adenoma / Colonic Polyps Type of study: Prognostic_studies Limits: Humans Language: En Journal: BMC Med Genomics Journal subject: GENETICA MEDICA Year: 2022 Document type: Article Affiliation country: Brazil Country of publication: United kingdom